- Global Pharma News & Resources

Celgene Corporation Chairman & CEO Mark J. Alles to Deliver Keynote Address at Washington State Life Science Summit

Life Science Washington:


    Chairman & CEO Mark Alles of Celgene to deliver keynote speech at Washington State Life Science Summit


October 26, 2018, 7:30 AM


Meydenbauer Center
11100 NE 6th St


Bellevue, Washington 98004

ABOUT THE EVENT: Life Science Washington welcomes Mark J. Alles, Chairman and CEO of Celgene Corporation, as keynote speaker for its annual state summit gathering. The event brings together hundreds of leaders from the life sciences industry as well as elected leaders. Celgene recently expanded its reach in the Pacific Northwest by completing its acquisition of Juno Therapeutics, based in Seattle. Organizers of the event look forward to hosting Mr. Alles and hearing his perspective on Celgene’s future in Washington state. Also, Senator Guy Palumbo will join other leaders in a panel discussion about the sector’s growing emphasis on workforce development.

ABOUT CELGENE: Celgene Corporation is an integrated global biopharma company focused on discovering, developing, and commercializing innovative drugs for patients worldwide. It has dominant product lines in cancer and inflammatory immune diseases.



Life Science Washington is an independent, non-profit 501(c)(6) trade association whose mission is to stimulate life science innovation, job creation and ecosystem vibrancy across Washington state through engagement, collaboration, promotion, and advocacy. Serving more than 500 members, Life Science Washington brings together research institutions, investors and innovators to grow the state’s life science economy. More information can be found at

View source version on

Editor Details

Last Updated: 25-Oct-2018